These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

528 related items for PubMed ID: 7652088

  • 41. Neuroleptic malignant syndrome.
    Abbott RJ, Loizou LA.
    Br J Psychiatry; 1986 Jan; 148():47-51. PubMed ID: 3513883
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. [Neuroleptic malignant syndrome--a case report on diagnosis, differential diagnosis and therapy of a life threatening complication of treatment with neuroleptics].
    Staud L, Pflug B.
    Psychiatr Prax; 1992 Jul; 19(4):114-8. PubMed ID: 1354879
    [Abstract] [Full Text] [Related]

  • 44. Successful treatment of a complicated case of neuroleptic malignant syndrome.
    Lappa A, Podestà M, Capelli O, Castagna A, Di Placido G, Alampi D, Semeraro F.
    Intensive Care Med; 2002 Jul; 28(7):976-7. PubMed ID: 12122539
    [Abstract] [Full Text] [Related]

  • 45. Neuroleptic malignant syndrome associated with the use of prochlorperazine in a patient with a recent history of antipsychotic-induced neuroleptic malignant syndrome.
    Musselman ME, Browning LA, Parker D, Saely S.
    Ann Pharmacother; 2011 Nov; 45(11):e61. PubMed ID: 21972252
    [Abstract] [Full Text] [Related]

  • 46. The neuroleptic malignant syndrome--a review.
    Gibb WR, Lees AJ.
    Q J Med; 1985 Aug; 56(220):421-9. PubMed ID: 2864716
    [Abstract] [Full Text] [Related]

  • 47. [Neuroleptic malignant syndrome].
    Nishijima K.
    Ryoikibetsu Shokogun Shirizu; 2003 Aug; (38):176-8. PubMed ID: 12876959
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. [Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) with disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease].
    Yamawaki Y, Ogawa N.
    Rinsho Shinkeigaku; 1991 Jan; 31(1):62-7. PubMed ID: 2044308
    [Abstract] [Full Text] [Related]

  • 50. [Successful treatment of the neuroleptic malignant syndrome using i.v. dantrolene sodium in the neurologic intensive care station].
    Rechlin T, Hilz MJ, Claus D.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 May; 26(3):156-60. PubMed ID: 1873425
    [Abstract] [Full Text] [Related]

  • 51. [Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Three case reports].
    Luchini F, Lattanzi L, Bartolommei N, Cosentino L, Casamassima F, Litta A, Mauri M, Cassano GB.
    Riv Psichiatr; 2012 May; 47(2):178-85. PubMed ID: 22622253
    [Abstract] [Full Text] [Related]

  • 52. [Acute renal failure in neuroleptic malignant syndrome].
    Wagner G, Rónai L.
    Orv Hetil; 1995 Oct 01; 136(40):2173-6. PubMed ID: 7566952
    [Abstract] [Full Text] [Related]

  • 53. Electroconvulsive therapy in drug resistant neuroleptic malignant syndrome.
    Patel AL, Shaikh WA, Khobragade AK, Soni HG, Joshi AS, Sahastrabuddhe GS.
    J Assoc Physicians India; 2008 Jan 01; 56():49-50. PubMed ID: 18472502
    [Abstract] [Full Text] [Related]

  • 54. Neuroleptic malignant syndrome with delayed onset of fever following risperidone administration.
    Norris B, Angeles V, Eisenstein R, Seale JP.
    Ann Pharmacother; 2006 Dec 01; 40(12):2260-4. PubMed ID: 17119106
    [Abstract] [Full Text] [Related]

  • 55. [Diagnostic and therapeutic aspects of neuroleptic malignant syndrome based on 12 cases].
    Sczesni B, Becker H, Schröder J, Bittkau S, von Baumgarten F, Truong DD, Przuntek H.
    Wien Klin Wochenschr; 1991 Dec 01; 103(1):21-6. PubMed ID: 1673042
    [No Abstract] [Full Text] [Related]

  • 56. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
    Ozen ME, Yumru M, Savas HA, Cansel N, Herken H.
    World J Biol Psychiatry; 2007 Dec 01; 8(1):42-4. PubMed ID: 17366349
    [Abstract] [Full Text] [Related]

  • 57. Precautionary measures reduce risk of definite neuroleptic malignant syndrome in newly typical neuroleptic-treated schizophrenia inpatients.
    Shiloh R, Valevski A, Bodinger L, Misgav S, Aizenberg D, Dorfman-Etrog P, Weizman A, Munitz H.
    Int Clin Psychopharmacol; 2003 May 01; 18(3):147-9. PubMed ID: 12702893
    [Abstract] [Full Text] [Related]

  • 58. Neuroleptic malignant syndrome in a burn patient.
    Still J, Friedman B, Law E, Deppe S, Epperly N, Orlet H.
    Burns; 1998 Sep 01; 24(6):573-5. PubMed ID: 9776099
    [Abstract] [Full Text] [Related]

  • 59. Zuclopenthixol-induced neuroleptic malignant syndrome in an adolescent girl.
    Erermis S, Bildik T, Tamar M, Gockay A, Karasoy H, Ercan ES.
    Clin Toxicol (Phila); 2007 Sep 01; 45(3):277-80. PubMed ID: 17453880
    [Abstract] [Full Text] [Related]

  • 60. Neuroleptic malignant syndrome: life-threatening complication of neuroleptic treatment in adolescents with affective disorder.
    Joshi PT, Capozzoli JA, Coyle JT.
    Pediatrics; 1991 Feb 01; 87(2):235-9. PubMed ID: 1670966
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.